Recent Advancements on the Use of Exosomes as Drug Carriers for the Treatment of Glioblastoma

Glioblastoma (GBM) is the most common and aggressive cancer of the brain. Presently, GBM patients have a poor prognosis, and therapy primarily aims to extend the life expectancy of affected patients. The current treatment of GBM in adult cases and high-grade gliomas in the pediatric population invol...

Descripción completa

Detalles Bibliográficos
Autores principales: Galardi, Angela, De Bethlen, Alexander, Di Paolo, Virginia, Lampis, Silvia, Mastronuzzi, Angela, Di Giannatale, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142357/
https://www.ncbi.nlm.nih.gov/pubmed/37109493
http://dx.doi.org/10.3390/life13040964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142357/
https://www.ncbi.nlm.nih.gov/pubmed/37109493
http://dx.doi.org/10.3390/life13040964

Ejemplares similares